Oral Presentation (Virtual)
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
The rapid evolution of vaccine science has accelerated interest in nanotechnology-based strategies aimed at improving immune precision, vaccine stability, and translational performance. Nanovaccines have emerged as versatile platforms capable of addressing critical limitations of [....] » Read More
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the subclin [....] » Read More
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Biodesigners, biotechnologists and biomanufacturers are beginning to realize the promise of Personalized and Precision Medicine (PPM), translating to direct benefit to patients or persons-at-risk. Both PPM, personalized vaccinomics and nanobiotechnologies are being integrated in [....] » Read More
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya
Background: Despite national progress in Kenya’s Expanded Program on Immunization (KEPI), vaccine availability and equitable access remain uneven across sub-counties. Awendo Sub-county in Migori County continues to face challenges related to inconsistent vaccine supply [....] » Read More
Title : From local pilots to national policy: Key issues and challenges in implementing nationwide HPV vaccination in China
Shenglan Tang, Duke Global Health Institute, United States
In October 2025, China announced the inclusion of human papillomavirus (HPV) vaccination into the National Immunization Program (NIP), marking the first addition of a new vaccine to the national schedule since 2008 and the first to explicitly target adolescents rather than young [....] » Read More
Title : Recombinant BCG vaccine as a potent anti tuberculosis vaccine candidate
Sajal Dey, BRIC-Centre for DNA Fingerprinting and Diagnostics, India
Tuberculosis (TB) is a significant global health challenge; it has been responsible for more human lives lost than any other infectious disease. BCG is the only pre-emptive vaccine against tuberculosis. However, the variable efficacy of BCG is well acknowledged fact which prompte [....] » Read More